An observational study in Menopause and Menopause Related Conditions, sponsored by Singapore General Hospital. Recruiting at 1 site in Singapore. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-08.
Sponsored by Singapore General Hospital · Observational
The aim of this study is to achieve expert consensus on the management of menopause in the Asia-Pacific
The aim of this study is to achieve expert consensus on the management of menopause in the Asia-Pacific. The experience of the menopause is deeply rooted in sociocultural perceptions unique to each population. Thus, the management of menopausal symptoms and other conditions related to the menopause also vary from region to region.
The investigators will use a modified Delphi method involving the participation of experts from various countries in the Asia-Pacific. The objective of this study is to achieve consensus on various aspects of the management of the menopause in the Asia-Pacific.
This study will involve several rounds of Delphi surveys, administered via Google Forms, Microsoft Word or PDF. Each survey questionnaire contains
Singapore General Hospital is the lead sponsor of 266 studies on the registry; 57 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Physicians with experience in treating menopause
Inclusion Criteria:
Experience in treating menopause
Other: No intervention to be performed
No intervention to be performed. Anonymous survey only.
Percentage of participants who vote for the same option on a series of survey questions
Time frame: 2023-2024
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Singapore General Hospital